6LX-13683-47270 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-25
Dose 1 — Moderna
2022-06-27
Registered in v-safe
2022-06-27
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Site: Pain, Redness · Fever · Irritability/crying, Loss of appetite

Under 3 check-in
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-02
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-09
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-16
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-23
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-30
Survey response — day 35, dose 1, under 3
MedDRA: Nasopharyngitis — Feeling: Fair

Free text: Common cold

MedDRA releases: 2024-11 · check-in free text available
2022-09-26
Health check-in — 3 months, dose 1, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-25	Moderna	No

Free text

Release 12 (Under 3) — day 35, dose 1, under 3

2022-07-30

Symptoms: Common cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Nasopharyngitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release